AORTHEON is a biotechnology company focused on developing innovative therapies for cardiovascular diseases. Their research often centers on addressing issues like heart failure and aortic diseases through advanced drug development and targeted treatments. The company's goal is to improve patient outcomes by leveraging cutting-edge science and technology in the field of cardiology.